Blocking serine protease (TMPRSS2) by Bromhexine; looking at potential treatment to prevent COVID-19 infection

Authors

Ramin Tolouian, Division of Nephrology, University of Arizona, Tucson, AZ, USAFollow
Audrey C. Tolouian, School of Nursing, The University of Texas at El Paso, El Paso, TX, USAFollow
Mohammadreza Ardalan, Kidney Research Center, Tabriz University of Medical Sciences, Tabriz, IranFollow

Author Credentials

Ramin Tolouian MD Audrey Tolouian EdD, MSN, RN-CNE Mohammadreza Ardalan MD

Author ORCID Identifier

Ramin Tolouian: 0000-0003-2242-9310

Audrey Tolouian: 0000-0002-9764-8510

Keywords

Serine protease, TMPRSS2, COVID 19, Bromhexine, Virus priming, Coronavirus Treatment, prevention, Rural area

Disciplines

Biological Phenomena, Cell Phenomena, and Immunity | Infectious Disease | Medicine and Health Sciences

Abstract

Not applicable. Manuscript is being submitted under Viewpoints category.

Recommended Citation

Tolouian R, Tolouian AC, Ardalan M. Blocking serine protease (TMPRSS2) by Bromhexine; looking at potential treatment to prevent COVID-19 infection. Marshall J Med. 2020; 6(3): 11 DOI: https://doi.org/10.33470/2379-9536.1286.